Gsk Share Discussion Threads

[patientcapital] 07/2/2024 16:30

Decent showing in a down market.

[tradermichael] 06/2/2024 13:24

DREAMM-7 phase III trial shows Blenrep combination nearly tripled median progression-free survival versus standard of care combination in patients with relapsed/refractory multiple myeloma.

· 59% reduction in risk of disease progression or death observed in patients with Blenrep combination versus standard of care daratumumab combination

· 36.6 months of median progression-free survival observed with Blenrep combination versus 13.4 months in daratumumab combination

· Strong, clinically meaningful trend in overall survival favouring Blenrep combination was observed with 43% reduction in risk of death

[tradermichael] 06/2/2024 08:37

GSK's RSV vaccine, Arexvy, accepted under Priority Review in US for the prevention of RSV disease in adults aged 50-59 at increased risk.

· Application supported by positive results of a phase III trial showing immune response and acceptable tolerability profile in this population

· Adults aged 50 and above with underlying medical conditions are at increased risk for RSV disease.

· GSK is the first company to file for regulatory approval to extend RSV vaccination to adults aged 50-59 at increased risk

· US FDA has set a Prescription Drug User Fee Act action date of 7th June 2024.

[tradermichael] 06/2/2024 08:35

GSK's regulatory application for Shingrix for the prevention of shingles in at-risk adults aged 18 and over accepted for review by China National Medical Products Administration.

· Shingrix already approved in China for adults aged 50 years and over

· Application could expand populations eligible to benefit from protection against shingles to include adults with an increased risk of the disease

· Approximately six million cases of shingles in China each year, with the incidence over three times higher for adults at increased risk compared to the general population

[panache1] 06/2/2024 07:45

A few nice RNSs today...positive momentum

[alibizzle] 06/2/2024 07:06

Hoping this reaches £17 by end of week , if it ever reaches £17.50 then I can break even after 18 months of misery. Will wait till.feb 22 nd for dividend and hopefully zantac news and decide .

[dudishes] 05/2/2024 16:47

Tuffymatt,

Hope you jumped into both, DGE, I did research, back in.

GSK, a punt (toss up between this and AZM), chose GSK.

1562. More luck than judgement, but your called it right, WD.

[tradermichael] 05/2/2024 12:32

Its still way to cheap. This price in 12m time will look very cheap.

[mj19] 05/2/2024 12:22

Think long term if it drops just top up

[mister md] 05/2/2024 12:16

This is going up in a very 'non-FTSE-stock' kind of way !!

[montyhedge] 05/2/2024 09:49

DB raising target 1950p very good, because they are tough on price targets.

[igoe104] 05/2/2024 08:38

Everything comes down to momentum with shares.

[supermarky] 05/2/2024 08:10

Things definitely looking up here at the moment

[dplewis1] 05/2/2024 08:02

Deutsche Bank raises target price to 1950p from 1850p

[tradermichael] 02/2/2024 16:27

Cup and handle?

[supermarky] 02/2/2024 15:51

this seems like a breakout

[rikky72] 02/2/2024 15:44

Nice to see £16 broken

[tradermichael] 02/2/2024 10:28

It might take some more time as the profit-takers drop off and fresh buyers come in .... ;0)

[montyhedge] 02/2/2024 10:23

If they break 1600p hopefully thats support level and not resistance level.

[pcok] 01/2/2024 18:02

On the ADVFN chart looks to be the highest close since the demerger. In addition 2 people in the know buying shares. Hope it lasts...

[tuftymatt] 01/2/2024 10:23

Hopefully we can now push on to 1620+ in the short term.

Good luck all 👍🏻

[alibizzle] 01/2/2024 10:22

Yeah surely this means everyone has to get payed in settlements? So they admit liability but at that same time don't admit liability. WTF

[disc0dave46] 01/2/2024 09:54

Not exactly defending itself is it, paying out to anyone that sues. Opening the floodgates IMO.

[steeplejack] 01/2/2024 09:12

Oh well,only a few hours until Wall Street opens and we'll get a response!